Convection-enhanced delivery of a transforming growth factor-beta2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142).
第一作者:
Marc C,Chamberlain
作者:
医学主题词
抗肿瘤药(Antineoplastic Agents);脑肿瘤(Brain Neoplasms);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);药物释放系统(Drug Delivery Systems);神经胶质瘤(Glioma);人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);寡脱氧核糖核苷酸类(Oligodeoxyribonucleotides);随机对照试验(主题)(Randomized Controlled Trials as Topic);存活率(Survival Rate);硫代核苷酸类(Thionucleotides);转化生长因子β2(Transforming Growth Factor beta2);治疗结果(Treatment Outcome)
DOI
10.1093/neuonc/nor048
PMID
21558078
发布时间
2021-10-20
- 浏览3
Neuro-oncology
558-9; author reply 561-2页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



